252
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Cytokines and parturition: investigating adiponectin, TNF-α, and IL-6 in mother–newborn pairs

, , , , , & show all
Pages 9249-9256 | Received 18 Jan 2021, Accepted 31 Dec 2021, Published online: 13 Feb 2022

References

  • Yockey LJ, Iwasaki A. Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity. 2018;49(3):397–412.
  • Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784–1792.
  • Fuglsang J, Skjaerbaek C, Frystyk J, et al. A longitudinal study of serum adiponectin during normal pregnancy. BJOG. 2006;113(1):110–113.
  • Kajantie E, Hytinantti T, Hovi P, et al. J cord plasma adiponectin: a 20-fold rise between 24 weeks gestation and term. Clin Endocrinol Metab. 2004;89(8):4031–4036.
  • Chen J, Tan B, Karteris E, et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia. 2006;49(6):1292–1302.
  • Corbetta S, Bulfamante G, Cortelazzi D, et al. Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab. 2005;90(4):2397–2402.
  • Lain KY, Daftary AR, Ness RB, et al. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407–411.
  • Retnakaran A, Retnakaran R. Adiponectin in pregnancy: implications for health and disease. Curr Med Chem. 2012;19(32):5444–5450.
  • Jones SA. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol. 2005;175(6):3463–3468.
  • Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379–1406.
  • Brandt C, Pedersen BK. The role of exercise-induced myokines in muscle homeostasis and the defense against chronic diseases. J Biomed Biotechnol. 2010;2010:520258.
  • Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin-1beta and interleukin-6 by fragments of term human placental villi: signalling pathways and effects of tumour necrosis factor alpha and mode of delivery. Placenta. 2002;23(6):467–474.
  • Schulpis KH, Vlachos GD, Karikas GA, et al. The effect of the mode of delivery on maternal-neonatal interleukin-6, biogenic amine and their precursor amino acid concentrations. Clin Chem Lab Med. 2008;46(11):1624–1630.
  • Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65.
  • Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, et al. Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review. Clin Rev Allergy Immunol. 2017;53(1):40–53.
  • Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta. 2014;35(4):241–248.
  • Deibert C, Ferrari N, Flöck A, et al. Adipokine–myokine–hepatokine compartment-system in mothers and children: an explorative study. Contemp Clin Trials Commun. 2016;3:1–5.
  • Flöck A, Weber SK, Ferrari N, et al. Determinants of brain-derived neurotrophic factor (BDNF) in umbilical cord and maternal serum. Psychoneuroendocrinology. 2016;63:191–197.
  • Telschow A, Ferrari N, Deibert C, et al. High maternal and low cord blood leptin are associated with BMI-SDS gain in the first year of life. Obes Facts. 2019;12(5):575–585.
  • Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762–769.
  • Garcés MF, Sanchez E, Torres-Sierra AL, et al. Brain-derived neurotrophic factor is expressed in rat and human placenta and its serum levels are similarly regulated throughout pregnancy in both species. Clin Endocrinol. 2014;81(1):141–151.
  • Fujita K, Tatsumi K, Kondoh E, et al. Differential expression and the anti-apoptotic effect of human placental neurotrophins and their receptors. Placenta. 2011;32(10):737–744.
  • Eyileten C, Kaplon-Cieslicka A, Mirowska-Guzel D, et al. Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus. J Diabetes Res. 2017;2017:2823671.
  • Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8(2):93–100.
  • Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380(1–2):24–30.
  • Manni L, Nikolova V, Vyagova D, et al. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol. 2005;102(1):169–171.
  • Cortelazzi D, Corbetta S, Ronzoni S, et al. Maternal and fetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66(3):447–453.
  • Dhobale M, Mehendale S, Pisal H, et al. Association of brain-derived neurotrophic factor and tyrosine kinase B receptor in pregnancy. Neuroscience. 2012;216:31–37.
  • Fujinami A, Ohta K, Obayashi H, et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem. 2008;41(10–11):812–817.
  • Su SC, Sun MT, Wen M, et al. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men. Int J Psychiatry Med. 2011;42(3):211–226.
  • Bai H, Zhao L, Liu H, et al. Adiponectin confers neuroprotection against cerebral ischemia–reperfusion injury through activating the cAMP/PKA-CREB-BDNF signaling. Brain Res Bull. 2018;143:145–154.
  • Jarvenpaa J, Vuoristo JT, Santaniemi M, et al. Adiponectin induced placental cell apoptosis could be mediated via the ADIPOR1-receptor in pre-eclampsia with IUGR. J Perinat Med. 2009;37(3):257–262.
  • Ninomiya M, Numakawa T, Adachi N, et al. Cortical neurons from intrauterine growth retardation rats exhibit lower response to neurotrophin BDNF. Neurosci Lett. 2010;476(2):104–109.
  • Treviño-Garza C, Villarreal-Martínez L, Estrada-Zúñiga CM, et al. Leptin, IL-6 and TNF-α levels in umbilical cord blood of healthy term newborns in relation to mode of delivery. J Obstet Gynaecol. 2016;36(6):719–721.
  • Zanardo V, Soldà G, Trevisanuto D. Elective cesarean section and fetal immune-endocrine response. Int J Gynaecol Obstet. 2006;95(1):52–53.
  • Nandanan B, Chua MC, Chiang WC, et al. Influence of mode of delivery on cytokine expression in cord blood. Hum Immunol. 2019;80(7):533–536.
  • Malamitsi-Puchner A, Protonotariou E, Boutsikou T, et al. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev. 2005;81(4):387–392.
  • Kiriakopoulos N, Grigoriadis S, Maziotis E, et al. Investigating stress response during vaginal delivery and elective cesarean section through assessment of levels of cortisol, interleukin 6 (IL-6), growth hormone (GH) and insulin-like growth factor 1 (IGF-1). J Clin Med. 2019;8(8):1112.
  • Fukuda H, Masuzaki H, Ishimaru T. Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes. Int J Gynaecol Obstet. 2002;77(2):123–129.
  • De Jongh RF, Puylaert M, Bosmans E, et al. The fetomaternal dependency of cord blood interleukin-6. Am J Perinatol. 1999;16(3):121–128.
  • Hebisch G, Neumaier-Wagner PM, Huch R, et al. Maternal serum interleukin-1 beta, -6 and -8 levels and potential determinants in pregnancy and peripartum. J Perinat Med. 2004;32:475–480.
  • Entringer S, Buss C, Wadhwa PD. Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr Opin Endocrinol Diabetes Obes. 2010;17(6):507–516.
  • Haghshenas-Mojaveri M, Mohammadzadeh I, Al-Sadat Bouzari Z, et al. The comparison of serum interleukin-6 of mothers in vaginal and elective cesarean delivery. Caspian J Intern Med. 2014;5:223–226.
  • Melczer Z, Bánhidy F, Csömör S, et al. Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropometric parameters of newborns. Acta Obstet Gynecol Scand. 2003;82(5):432–438.
  • Frühbeck G, Salvador J. Relation between leptin and the regulation of glucose metabolism. Diabetologia. 2000;43(1):3–12.
  • Xu J, Zhao YH, Chen YP, et al. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Scientific World Journal. 2014;2014:1–12.
  • Laml T, Hartmann BW, Ruecklinger E, et al. Maternal serum leptin concentrations do not correlate with cord blood leptin concentrations in normal pregnancy. J Soc Gynecol Investig. 2001;8(1):43–47.
  • Pantham P, Aye ILM, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015;36(7):709–715.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.